In her primary care practice, Dr
Staying on a restrictive diet indefinitely starves beneficial bacteria too
This is a prevalent scenario with my clients and generally points to levels of estrogen that are out of balance with progesterone
GLP-1 Therapies: Safety and Clinical Considerations GLP-1based therapies, including newer dual- and triple-agonists targeting GLP-1, GIP, and glucagon pathways, offer substantial metabolic benefits but require thoughtful use [29]
Key Takeaways Injectable GLP-1 medications like Mounjaro demonstrate proven weight loss of 15-20%, while patches lack scientific evidence of effectiveness
There are several mechanisms by which glucagon prevents hypoglycemia, such as induction of hepatic gluconeogenesis and glycogenolysis, and the inhibition of hepatic glycogenesis